Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engineered Cytokines for Cancer and Autoimmune Disease Immunotherapy.
Uricoli B, Birnbaum LA, Do P, Kelvin JM, Jain J, Costanza E, Chyong A, Porter CC, Rafiq S, Dreaden EC. Uricoli B, et al. Adv Healthc Mater. 2021 Aug;10(15):e2002214. doi: 10.1002/adhm.202002214. Epub 2021 Mar 9. Adv Healthc Mater. 2021. PMID: 33690997 Free PMC article. Review.
Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines.
Birnbaum LA, Sullivan EC, Do P, Uricoli B, Raikar SS, Porter CC, Henry CJ, Dreaden EC. Birnbaum LA, et al. Among authors: uricoli b. Biomacromolecules. 2023 Mar 13;24(3):1164-1172. doi: 10.1021/acs.biomac.2c01207. Epub 2023 Feb 6. Biomacromolecules. 2023. PMID: 36745712 Free PMC article.
Three-Dimensional Cell Culture System for Tendon Tissue Engineering.
Son YH, Yang DH, Uricoli B, Park SJ, Jeong GJ, Chun HJ. Son YH, et al. Among authors: uricoli b. Tissue Eng Regen Med. 2023 Jul;20(4):553-562. doi: 10.1007/s13770-023-00550-z. Epub 2023 Jun 6. Tissue Eng Regen Med. 2023. PMID: 37278865 Free PMC article. Review.
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.
Lin HK, Uricoli B, Freeman R, Hossian AN, He Z, Anderson JYL, Neffling M, Legier JM, Blake DA, Doxie DB, Nair R, Koff JL, Dhodapkar KM, Shanmugam M, Dreaden EC, Rafiq S. Lin HK, et al. Among authors: uricoli b. Adv Healthc Mater. 2024 Jun;13(14):e2302425. doi: 10.1002/adhm.202302425. Epub 2024 Feb 14. Adv Healthc Mater. 2024. PMID: 38245855
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AML.
Kelvin JM, Jain J, Thapa A, Qui M, Birnbaum LA, Moore SG, Zecca H, Summers RJ, Costanza E, Uricoli B, Wang X, Jui NT, Fu H, Du Y, DeRyckere D, Graham DK, Dreaden EC. Kelvin JM, et al. Among authors: uricoli b. bioRxiv [Preprint]. 2023 Mar 15:2023.03.13.531236. doi: 10.1101/2023.03.13.531236. bioRxiv. 2023. Update in: Pharm Res. 2023 Sep;40(9):2133-2146. doi: 10.1007/s11095-023-03596-9 PMID: 36993676 Free PMC article. Updated. Preprint.